Study on the Safety and Efficacy of Dalbavancin Versus Active Comparator in Adult Participants With Osteomyelitis
Clinical trial NCT02685033 · COMPLETED
Trial details
- NCT number
- NCT02685033
- Sponsor
- Durata Therapeutics Inc., an affiliate of Allergan plc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-15
- Primary completion
- 2017-12-12
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.